Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-31 @ 12:01 AM
Study NCT ID:
NCT04271956
Status:
RECRUITING
Last Update Posted:
2024-12-30
First Post:
2020-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for Patients with Richter Transformation
Sponsor:
German CLL Study Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-14
First Submit QC Date:
None
Study First Post Date:
2020-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-27
Last Update Post Date:
2024-12-30
Last Update Post Date Type:
ACTUAL